Together, our findings identify increased osteoclast activity as a significant contributor to Rett-associated osteopenia and suggest that skeletal pathology in <i>Mecp2</i> deficiency progresses from an early low-turnover state to a later phase of increased osteoclast resorption. This evidence concerns the gene MECP2 and Osteopenia.